Company Clarus Therapeutics Holdings, Inc.
Equities
CRXT
US18271L1070
Pharmaceuticals
Business Summary
Number of employees: 16
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Dudley
FOU | Founder | 69 | 03-12-31 |
Jay Newmark
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kara Stancell
IRC | Investor Relations Contact | - | - |
Sales & Marketing | - | 20-02-29 | |
Corporate Officer/Principal | - | 22-01-16 | |
James Holloway
PRN | Corporate Officer/Principal | - | - |
Lawrence Perkins
PRN | Corporate Officer/Principal | 47 | - |
Mike Cleveland
SAM | Sales & Marketing | - | 22-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Dudley
FOU | Founder | 69 | 03-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 52,020,731 | 50,674,645 ( 97.41 %) | 0 | 97.41 % |
Company contact information
Clarus Therapeutics Holdings, Inc.
355 South Grand Avenue Suite 1450
90071, Los Angeles
+
http://clarustherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |